The microbiome plays a crucial role in regulating brain development, function, and behavior through various pathways connecting the gut to the central nervous system (CNS). This review highlights emerging evidence that gut bacteria influence neurological outcomes, altering behavior and potentially affecting the onset and severity of nervous system disorders. The microbiota's impact on the nervous system is increasingly recognized, with studies showing that it can modulate mood, anxiety, and social behaviors. For example, germ-free (GF) mice exhibit altered stress responses, increased corticosterone levels, and reduced brain-derived neurotrophic factor (BDNF), which can be reversed by re-colonization with a diverse microbiota. Probiotic treatments, such as Lactobacillus rhamnosus and Bifidobacterium infantis, have been shown to reduce anxiety and depression-like behaviors in mice, suggesting that the microbiota can actively modulate neurological function. Additionally, the microbiota influences neurotransmitter levels, such as serotonin (5-HT), which is critical for mood regulation. The microbiota can also affect the blood-brain barrier (BBB) integrity, allowing microbial-derived molecules to influence neurological function. Furthermore, immune signaling, particularly pro-inflammatory cytokines, can mediate neurological disorders, including depression and neurodegenerative diseases. The microbiome's role in modulating immune function and neurophysiology is increasingly evident, with implications for the treatment of psychiatric and neurodegenerative disorders. Future research aims to elucidate the precise mechanisms by which the microbiome influences neurological function and to explore potential therapeutic applications, such as probiotic interventions, for neurological diseases. The gut-microbiome-brain connection represents a promising area of research with significant implications for understanding and treating neurological conditions.The microbiome plays a crucial role in regulating brain development, function, and behavior through various pathways connecting the gut to the central nervous system (CNS). This review highlights emerging evidence that gut bacteria influence neurological outcomes, altering behavior and potentially affecting the onset and severity of nervous system disorders. The microbiota's impact on the nervous system is increasingly recognized, with studies showing that it can modulate mood, anxiety, and social behaviors. For example, germ-free (GF) mice exhibit altered stress responses, increased corticosterone levels, and reduced brain-derived neurotrophic factor (BDNF), which can be reversed by re-colonization with a diverse microbiota. Probiotic treatments, such as Lactobacillus rhamnosus and Bifidobacterium infantis, have been shown to reduce anxiety and depression-like behaviors in mice, suggesting that the microbiota can actively modulate neurological function. Additionally, the microbiota influences neurotransmitter levels, such as serotonin (5-HT), which is critical for mood regulation. The microbiota can also affect the blood-brain barrier (BBB) integrity, allowing microbial-derived molecules to influence neurological function. Furthermore, immune signaling, particularly pro-inflammatory cytokines, can mediate neurological disorders, including depression and neurodegenerative diseases. The microbiome's role in modulating immune function and neurophysiology is increasingly evident, with implications for the treatment of psychiatric and neurodegenerative disorders. Future research aims to elucidate the precise mechanisms by which the microbiome influences neurological function and to explore potential therapeutic applications, such as probiotic interventions, for neurological diseases. The gut-microbiome-brain connection represents a promising area of research with significant implications for understanding and treating neurological conditions.